Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Morrison, M. F. Articles by Evans, D. L. Search for Related Content PubMed Citation Articles by Morrison, M. F. Articles by Evans, D. L. Gender AIDS/HIV Anxiety Disorders (General) Depression

Depressive and Anxiety Disorders in Women With HIV Infection

OBJECTIVE: This study examined whether there were differences in the rate of depressive and anxiety disorders between HIV-infected women (N=93) and a comparison group of uninfected women (N=62). Secondary objectives were to examine correlates of depression in HIV-infected women—including HIV disease stage and protease inhibitor use—and the associations between symptoms of depression or anxiety and other potential predictor variables. METHOD: Subjects underwent extensive semiannual clinical, psychiatric, neuropsychological, and immunological evaluations. Depressive and anxiety disorder diagnoses were assessed by using the Structured Clinical Interview for DSM-IV. Symptoms of depression and anxiety were evaluated with the Hamilton Depression Rating Scale (the 17-item version and a modified 11-item version) and the Hamilton Anxiety Rating Scale, respectively. RESULTS: The rate of current major depressive disorder was four times higher in HIV-seropositive women (19.4%) than in HIV-seronegative women (4.8%). Mean depressive symptom scores on the 17-item Hamilton depression scale also were significantly higher, overall, in the HIV-infected women (mean=8.7, SD=8.0) relative to comparison subjects (mean=3.3, SD=5.8). There was no significant between-group difference in the rate of anxiety disorders. However, HIV-seropositive women had significantly higher anxiety symptom scores (mean=8.8, SD=8.9) than did HIV-seronegative women (mean=3.6, SD=5.5). Both groups had similar substance abuse/dependence histories, but adjusting for this factor had little impact on the relationship of HIV status to current major depressive disorder. CONCLUSIONS: HIV-seropositive women without current substance abuse exhibited a significantly higher rate of major depressive disorder and more symptoms of depression and anxiety than did a group of HIV-seronegative women with similar demographic characteristics. These controlled, clinical findings extend recent epidemiologic findings and underscore the importance of adequate assessment and treatment of depression and anxiety in HIV-infected women.

This article has been cited by other articles:

				C. A. Mellins, E. Brackis-Cott, C. Dolezal, C. S. Leu, C. Valentin, and H. F.L. Meyer-Bahlburg Mental Health of Early Adolescents from High-risk Neighborhoods: The Role of Maternal HIV and Other Contextual, Self-Regulation, and Family Factors J. Pediatr. Psychol., February 4, 2008; (2008) jsn004v1. [Abstract] [Full Text] [PDF]

				E. Brackis-Cott, C. A. Mellins, C. Dolezal, and D. Spiegel The Mental Health Risk of Mothers and Children: The Role of Maternal HIV Infection The Journal of Early Adolescence, February 1, 2007; 27(1): 67 - 89. [Abstract] [PDF]

				D. G. Cruess, S. D. Douglas, J. M. Petitto, T. T. Have, D. Gettes, B. Dube, M. Cary, and D. L. Evans Association of Resolution of Major Depression With Increased Natural Killer Cell Activity Among HIV-Seropositive Women Am J Psychiatry, November 1, 2005; 162(11): 2125 - 2130. [Abstract] [Full Text] [PDF]

				Don't Overlook Depression and Anxiety in HIV-Positive Women Journal Watch Women's Health, July 23, 2002; 2002(723): 5 - 5. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us